We recently published a list of While Wall Street Naps, These 10 Stocks Run Wild. In this article, we are going to take a ...

Ten firms led a market rally with whopping gains on Thursday, outperforming the lackluster performance of the major indices ...

The Food and Drug Administration (FDA) has approved Starjemza ® (ustekinumab-hmny), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Starjemza, ...

The FDA designates 2 biosimilars as interchangeable, enhancing access to treatments for inflammatory diseases and multiple ...

The designation allows pharmacists to substitute it for Humira without prescriber approval (per state law), which expands ...

It’s no secret that prescription drugs can take a toll on your wallet. One classification of medication in particular—biologics—has had an oversized impact on the rising cost of prescription drugs.

Some Michigan hospitals are marking up prices by thousands of dollars above what they pay manufacturers for certain prescription drugs, according to a new report from the Michigan Health Purchasers ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.

This designation is meaningful as it signifies our continued commitment to making biosimilars more accessible. Both biosimilars and interchangeable biosimilars are highly similar and have no ...

There's a need for early anti-tumor necrosis factor (TNF) therapy in inflammatory bowel disease (IBD), with new data showing ...